Leeds Fetal Medicine Unit Website

Meetings, Education & Research

Currently the department is actively involved in recruiting for

Meridian study
RAPID study
Pelican study
CGH in prenatal diagnosis
PONTI study

CGH in prenatal diagnosis

The department is currently involved in a research study based in Leeds looking at a potentially different way to investigate babies with abnormal ultrasound scans, such as an increased nuchal translucency. The study is analysing a different kind of genetic test called array CGH, and women are invited to participate if we find an abnormality on their baby's ultrasound scan. In these cases, we often offer a test such as amniocentesis or CVS to look for chromosomal problems. If families agree to be involved, then the research team would use surplus samples from these tests to see if array CGH could be useful in the future.

Leaflets for participation in the study for download

Clinical proforma to be completed by clinician and sent with sample

Partner consent form

Maternal consent form

Patient information leaflet

Contact:

Dr Kelly Cohen

St James University Hospital

PONTI study

This study is being caried out by UCL in London and is using a new drug (Inositol) to try and prevent NTD. The drug must be started pre-conceptually and is available to any patient who has previously had a NTD affected pregnancy.

Recruitment does not require local ethics approval.

Link to study website with patient information etc.

http://www.ich.ucl.ac.uk/ich/academicunits/Neural_development/Custom%20Menu_03

Contact:

Katie Burren 020 7905 2326

If you have techinical problems with this website please contact webmaster@leedsth.nhs.uk.